Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference
Sight Sciences (Nasdaq: SGHT), an eyecare technology company, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference in New York. The company's management will deliver a presentation on Tuesday, December 3, 2024, at 12:30 pm PT / 3:30 pm ET. A live webcast and recording of the fireside chat will be available to interested parties through the 'Investors' section of Sight Sciences' website at investors.sightsciences.com.
Sight Sciences (Nasdaq: SGHT), un'azienda di tecnologia per la salute degli occhi, ha annunciato la sua partecipazione alla 36ª Conferenza Annuale sulla Salute di Piper Sandler a New York. La direzione dell'azienda terrà una presentazione martedì 3 dicembre 2024, alle 12:30 ora pacifica / 15:30 ora orientale. Un webcast in diretta e la registrazione della chiacchierata informale saranno disponibili per le parti interessate nella sezione 'Investitori' del sito web di Sight Sciences, all'indirizzo investors.sightsciences.com.
Sight Sciences (Nasdaq: SGHT), una empresa de tecnología para el cuidado ocular, ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler en Nueva York. La dirección de la empresa realizará una presentación el martes 3 de diciembre de 2024, a las 12:30 pm PT / 3:30 pm ET. Una transmisión web en vivo y la grabación de la charla estarán disponibles para las partes interesadas a través de la sección 'Inversores' del sitio web de Sight Sciences en investors.sightsciences.com.
Sight Sciences (Nasdaq: SGHT), 안과 기술 회사가 뉴욕에서 열리는 Piper Sandler 제36회 연례 의료 회의에 참가한다고 발표했습니다. 회사의 경영진은 2024년 12월 3일 화요일, 오후 12:30 PT / 오후 3:30 ET에 발표를 진행할 것입니다. 라이브 웹캐스트와 대화 내용의 녹화는 Sight Sciences 웹사이트의 '투자자' 섹션에서 관심 있는 분들을 위해 제공될 예정입니다: investors.sightsciences.com.
Sight Sciences (Nasdaq: SGHT), une entreprise de technologie ophtalmique, a annoncé sa participation à la 36ème Conférence Annuelle sur la Santé de Piper Sandler à New York. La direction de l'entreprise présentera une conférence le mardi 3 décembre 2024, à 12h30 PT / 15h30 ET. Un webinaire en direct et l'enregistrement de la discussion seront disponibles pour les parties intéressées dans la section 'Investisseurs' du site web de Sight Sciences à l'adresse investors.sightsciences.com.
Sight Sciences (Nasdaq: SGHT), ein Unternehmen für Augentechnologie, hat seine Teilnahme an der 36. jährlichen Healthcare-Konferenz von Piper Sandler in New York bekannt gegeben. Das Management des Unternehmens wird am Dienstag, den 3. Dezember 2024, um 12:30 Uhr PT / 15:30 Uhr ET eine Präsentation halten. Ein Live-Stream und eine Aufzeichnung des Gesprächs werden interessierten Parteien im Abschnitt 'Investoren' der Website von Sight Sciences unter investors.sightsciences.com zur Verfügung stehen.
- None.
- None.
MENLO PARK, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced that it will present at the upcoming Piper Sandler 36th Annual Healthcare Conference, in New York, NY.
Sight Sciences’ management is scheduled to present on Tuesday, December 3, 2024, at 12:30 pm PT / 3:30 pm ET. Interested parties may access a live and archived webcast of the fireside chat on the “Investors” section of the company’s website at: investors.sightsciences.com.
About Sight Sciences
Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients’ lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company’s OMNI® Surgical System is an implant-free glaucoma surgery technology (i) indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and (ii) CE Marked for the catheterization and transluminal viscodilation of Schlemm’s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma. Glaucoma is the world’s leading cause of irreversible blindness. The SION® Surgical Instrument is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company’s TearCare® System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (“MGD”), enabling clearance of gland obstructions by physicians to address the leading cause of dry eye disease. Visit www.sightsciences.com for more information.
Sight Sciences, the Sight Sciences logo, TearCare, SmartHub and SmartLids are trademarks of Sight Sciences registered in the United States. OMNI and SION are trademarks of Sight Sciences registered in the United States, European Union and other territories.
© 2024 Sight Sciences. All rights reserved.
Investor contact:
Philip Taylor
Gilmartin Group
415.937.5406
Investor.Relations@Sightsciences.com
Media contact:
pr@SightSciences.com
FAQ
When is Sight Sciences (SGHT) presenting at the Piper Sandler Healthcare Conference 2024?
How can I watch Sight Sciences' (SGHT) presentation at the Piper Sandler Conference?
Where is the Piper Sandler Healthcare Conference 2024 featuring Sight Sciences (SGHT) being held?
